Common Names: French lavender
Researchers studied Lavandula stoechas flower extract for potential pain relief effects and pathways involved. Essential for understanding plant-based analgesics for future medical applications.
Researchers analyzed Lavandula abrialis and Lavandula stoechas from Morocco for their chemical composition, antioxidant, and antimicrobial properties. Lavandula stoechas showed higher antioxidant and antibacterial activity, with potential for Ishwarone and Selina-3,7 (11)-diene as antibacterial and antioxidant agents.
The study developed and evaluated transdermal patches loaded with hydro-alcoholic extract and essential oil of L. for dementia treatment. The patches showed good physicochemical properties, sustained drug release, and non-Fickian release mechanisms. They could improve patient compliance in Unani medicine.
Mediterranean plant species contain phenolic compounds with potential to treat neurodegenerative diseases. 24 species studied, yielding 403 compounds, including gallic, vanillic, caffeic. 3 species show promise for protection against these diseases.
This study investigates the effect of Lavandula stoechas on wound healing in a diabetes model. Understanding this effect could help improve treatment for diabetic foot, a dangerous complication of diabetes with various negative impacts.
This study compared the effects of aromatherapy with breast milk, Lavandula stoechas, and Rosa damascena on reducing venipuncture pain in preterm infants, who frequently undergo painful procedures. Finding effective non-pharmacological pain management methods is important for their well-being.
Essential oils (EOs) and their compounds linalool and camphor were studied for their effectiveness in inhibiting two enzymes, LOX and ACE2. Gas chromatography was used to confirm the chemical composition of three EOs, each containing varying amounts of linalool and camphor. At 20 μg/mL, the EOs inhibited ACE2 by 25.4-34.1%, and LOX by 49.1-86.7%. Linalool and camphor showed remarkable ACE2 inhibition (77.1-85.1%) and LOX inhibition (67.2-92%) at 5 μg/mL. Further studies are needed to confirm safe use.